A new genome-wide association study identifies four genetic loci associated with primary spontaneous pneumothorax.

RENTON, Wash. [Nov. 12, 2024] – New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a ...

Comprehensive genomic profiling In cancer research, investigations into the genomic profiles of tumors have enabled clinical labs to identify mutations driving cancers. As technology advances and ...

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces ...

An expert emphasizes that genomic profiling—including both germline and somatic testing—is now essential in metastatic prostate cancer management because it identifies key mutations such as homologous ...

Flexible Capabilities to Enable Comprehensive Genomic Profiling Comprehensive Genomic profiling (CGP) is becoming standard of care in oncology. It allows clinicians to maximize clinical information ...

Introducing our In Focus on comprehensive genomic profiling, this video explores the three main methods available for investigating the genomic profiles of tumors, highlighting the pros and cons of ...

As comprehensive genomic profiling for solid tumors grows in popularity to rapidly identify cancer biomarkers, IDT’s suite of CGP solutions is designed to fit labs unique needs with pre-designed RNA- ...

Tumor genomic profiling has become an integral part of cancer care over the past several years. More than 75% of oncologists who responded to a 2017 survey said they used it in their practice, ...

New real-world data from Providence, Illumina, and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient's diagnosis, leads to better ...

A study reveals significant genomic differences in metastatic prostate cancer among veterans, highlighting the need for ...